Yok Lam Kwong MD (HK), FRCP (Edin), FRCPath, FHKCP, FHKCPath, FHKAM (Medicine), FHKAM (Pathology)

Professor Yok Lam Kwong is Chief of the Division of Haematology, Oncology and Bone Marrow Transplantation at the Department of Medicine, School of Clinical Medicine, The University of Hong Kong. He is specialized in hematology and haematopathology. His clinical work focuses on the management of hematological malignancies. His team has especial interests in the treatment of leukemias and T-cell and natural killer cell malignancies. His research centres on molecular pathogenetic pathways and novel treatment modalities in hematological neoplasms.

Together with the clinical pharmacology team in his department, Professor Kwong has pioneered the development and use of oral arsenic trioxide in the treatment of acute promyelocytic leukemia and other blood cancers. His research team is also actively involved in defining the molecular defects and optimal treatment protocols for T-cell and natural killer cell lymphomas, which are neoplasms prevalent in Asian populations.